FDA unveils six ICH guidelines ahead of meeting with Health Canada
A sign that the FDA’s non-Covid-related processes are beginning to normalize: The release of six guidelines from the International Council of Harmonisation.
Years in development, the ICH documents offer an international perspective on drug development, with these latest guidelines covering everything from recommendations to support the classification of drug substances, featured in the M9 guidance, to standards for nonclinical safety studies for pediatric medicines in the S11 guideline.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.